Search alternatives:
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
w decrease » we decrease (Expand Search), _ decrease (Expand Search), _ decreased (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
w decrease » we decrease (Expand Search), _ decrease (Expand Search), _ decreased (Expand Search)
-
1021
Effect of SNX5 S226 phosphorylation on the retrograde transport of CI-M6PR.
Published 2018Subjects: -
1022
Citrate cycle showing ISE6 proteins that exhibited increased/decreased expression following treatment to LGTV and UV-LGTV.
Published 2016“…Decreased expression of citrate synthase (CS) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was observed in LGTV-treated cells and decreased expression of fumarate hydratase (FH), aldolase A/B/C fructose-bisphosphate (ALDOA/B/C), and aldehyde dehydrogenase 2/1B1/3A2 family protein (ALDH2/1B1/3A2) was observed in both LGTV-infected and UV-LGTV—treated cells. …”
-
1023
-
1024
miR-150-5p inhibition modulates pyroptosis and FoxO3a/ARC signaling in ApoE<sup>-/-</sup> mice.
Published 2025Subjects: -
1025
Therapeutic effects of miR-150-5p inhibition on ox-LDL-induced pyroptosis in RAW264.7 macrophages.
Published 2025Subjects: -
1026
-
1027
-
1028
The effects of thioperamide and alpha-FMH on the amount of sleep/wake in WT and W/W<sup>v</sup> mice.
Published 2013“…<p>(A) Injection of thioperamide (ip), a H3 antagonist, at a high dose (10 mg/kg) increased wakefulness in both WT and W/W<sup>v</sup> mice for 3 hours. …”
-
1029
-
1030
-
1031
-
1032
-
1033
-
1034
-
1035
-
1036
Laquinimod prevents EAE and decreases encephalitogenicity of T cells.
Published 2012“…Representative FACS staining is shown including quantification (n = 4–5 mice per group). (E) Laquinimod decreases pathogenic potential of T cells. …”
-
1037
B2 decreases glycolytic intermediates in cells.
Published 2025“…<b>(C)</b> Heatmap of targeted metabolomic data. Each column is a separate biological replicate (n = 5). The box indicates the clustering of decreased downstream glycolytic intermediates in B2-treated cells. …”
-
1038
-
1039
-
1040